Wei Tang
机构:Union Hospital, Westchester Medical Center, Guangxi Medical University, National University of Singapore, Bengbu Medical College, Hunan Normal University, Shanxi Medical University, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Ruijin Hospital, National Cancer Center, First Affiliated Hospital of Guangzhou Medical University, Tongren Hospital, Indiana University Bloomington, Zhongshan Hospital, Second Hospital of Shanxi Medical University, Shanghai Institute of Hematology, Tongji Hospital, Shaoxing People's Hospital, Union Hospital, Huazhong University of Science and Technology, Indiana University, The University of Tokyo, Zhejiang University, Guangzhou Medical University · ORCID:0000-0003-0789-9971
发表论文 213 篇 · 总被引 3343 次 · h-index 31
代表论文
- Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients (2025 · Signal Transduction and Targeted Therapy · 被引 10)
- Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06) (2025 · Signal Transduction and Targeted Therapy · 被引 8)
- Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition (2025 · BioScience Trends · 被引 5)
- Machine learning‑based radiomics models for the prediction of metachronous liver metastases in patients with colorectal cancer: A multimodal study (2025 · Oncology Letters · 被引 5)
- Glycolysis-inhibiting tumor cell-derived microparticles to enhance immunogenic cell death for synergistic cancer immunotherapy (2025 · Biomaterials · 被引 4)
- Prognostic Value of 18F-FDG PET/CT in Neoadjuvant PD-1 Inhibitor-treated NSCLC (2025 · Clinical Nuclear Medicine · 被引 4)